Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses

Published:2017-07-01 Issue: Volume: Page:
ISSN:
Container-title:Clinical Research (Excluding Clinical Trials)
language:
Short-container-title:

Author:

Schmid Peter,Cruz Cristina,Braiteh Fadi S.,Eder Joseph Paul,Tolaney Sara,Kuter Irene,Nanda Rita,Chung Cathie,Cassier Philippe,Delord Jean-Pierre,Gordon Michael,Li Yijin,Liu Bo,O’Hear Carol,Fasso Marcella,Molinero Luciana,Emens Leisha A.

Publisher

American Association for Cancer Research

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11

2. Reconstruction of unreported subgroup survival data with PD-L1-low expression in advanced/metastatic triple-negative breast cancer using innovative KMSubtraction workflow;Journal for ImmunoTherapy of Cancer;2024-01

3. Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment;International Journal of Biological Sciences;2024

4. The differential effect of the immune system in breast cancer;Exploration of Medicine;2023-12-29

5. Development of Tumor Markers for Breast Cancer Immunotherapy;Current Molecular Medicine;2023-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP